These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.


BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

64 related articles for article (PubMed ID: 9501607)

  • 1. [Therapeutic strategy of chronic heart failure].
    Isnard R
    Rev Prat; 1997 Dec; 47(19):2139-45. PubMed ID: 9501607
    [TBL] [Abstract][Full Text] [Related]  

  • 2. [Modern therapy of cardiac insufficiency].
    Stojsić D; Jelkić N
    Med Pregl; 1999; 52(3-5):113-24. PubMed ID: 10518395
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Treatment of advanced heart failure.
    Jessup M; Brozena S
    Cardiol Rev; 2000; 8(3):148-57. PubMed ID: 11174888
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Incidence and risk factors of asymptomatic first-dose hypotension with angiotensin-converting enzyme inhibitors in chronic heart failure due to systolic dysfunction.
    Thanikachalam S; Manchanda SC
    Indian Heart J; 2003; 55(2):167-71. PubMed ID: 12921333
    [TBL] [Abstract][Full Text] [Related]  

  • 5. The therapeutic role of RAS blockade in chronic heart failure.
    Werner CM; Böhm M
    Ther Adv Cardiovasc Dis; 2008 Jun; 2(3):167-77. PubMed ID: 19124420
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Clinical and pharmacologic management of chronic heart failure associated with left ventricular systolic dysfunction.
    Parra D; Marshall R; Soisson K
    Lippincotts Prim Care Pract; 1999; 3(3):316-32. PubMed ID: 10711133
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Heart failure: recent advances in prevention and treatment.
    Fonarow GC
    Rev Cardiovasc Med; 2000; 1(1):25-33, 54. PubMed ID: 12457149
    [TBL] [Abstract][Full Text] [Related]  

  • 8. [Recent advances and limitations of medical treatment on heart failure].
    Momomura S
    Kyobu Geka; 2007 Jun; 60(6):484-7. PubMed ID: 17564066
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Heart failure: management of patients with left-ventricular systolic dysfunction.
    Clin Pract Guidel Quick Ref Guide Clin; 1994 Jun; (11):1-21. PubMed ID: 10892351
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Progression and management of chronic heart failure.
    Viganego F; Le Jemtel TH
    Panminerva Med; 2007 Sep; 49(3):109-18. PubMed ID: 17912147
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Guideline for the management of heart failure caused by systolic dysfunction: part II. Treatment.
    Chavey WE; Blaum CS; Bleske BE; Harrison RV; Kesterson S; Nicklas JM;
    Am Fam Physician; 2001 Sep; 64(6):1045-54. PubMed ID: 11578026
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Lessons from the management of chronic heart failure.
    McDonagh TA
    Heart; 2005 May; 91 Suppl 2(Suppl 2):ii24-7; discussion ii31, ii43-8. PubMed ID: 15831605
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Drug therapy for chronic heart failure due to left ventricular systolic dysfunction: a review. III. Angiotensin-converting enzyme inhibitors.
    Ascenção R; Fortuna P; Reis I; Carneiro AV
    Rev Port Cardiol; 2008 Sep; 27(9):1169-87. PubMed ID: 19044179
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Major adverse cardiac event predictors in survivors of myocardial infarction with asymptomatic left ventricular dysfunction or chronic heart failure.
    Kuch M; Janiszewski M; Mamcarz A; Cudnoch-Jedrzejewska A; Dłuzniewski M
    Med Sci Monit; 2009 Jun; 15(6):PH40-8. PubMed ID: 19478711
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Preventing congestive heart failure.
    Cohn JN
    Am Fam Physician; 1998 Apr; 57(8):1901-4. PubMed ID: 9575327
    [TBL] [Abstract][Full Text] [Related]  

  • 16. Should angiotensin receptor blockers be added to angiotensin-converting enzyme inhibitors in the treatment of heart failure?
    Ghanem FA; Movahed A
    Rev Cardiovasc Med; 2005; 6(4):206-13. PubMed ID: 16379016
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Tissue angiotensin-converting enzyme inhibitors for the prevention of cardiovascular disease in patients with diabetes mellitus without left ventricular systolic dysfunction or clinical evidence of heart failure: a pooled meta-analysis of randomized placebo-controlled clinical trials.
    Saha SA; Molnar J; Arora RR
    Diabetes Obes Metab; 2008 Jan; 10(1):41-52. PubMed ID: 18095949
    [TBL] [Abstract][Full Text] [Related]  

  • 18. [Treatment of chronic heart failure in the child].
    Bonnet D
    Arch Pediatr; 2001 Dec; 8(12):1379-82. PubMed ID: 11811037
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances in the management of chronic heart failure.
    Krum H; Liew D
    Aust Fam Physician; 2003; 32(1-2):39-43. PubMed ID: 12647658
    [TBL] [Abstract][Full Text] [Related]  

  • 20. [Neuro-hormonal mechanisms in heart failure -- from physiopathology to treatment].
    Cerqueira-Gomes M; Polónia J; Brandão F; Ramalhão C; da Faria DB
    Rev Port Cardiol; 2001 May; 20 Suppl 5():V-99-122; discussion V-123-5. PubMed ID: 11515306
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 4.